Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation

Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation

US Patent 9505824 · Granted Nov 29, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Information management apparatus and non-transitory computer-readable recording 2025
Anti-GPC3 antibody2024
Anti-GPC3 antibody2023
T-cell receptor2023
Anti-GPC3 antibody2020
Kit for diagnosing malignant melanoma2016
Cancer antigen and use thereof2016
Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-p2013
Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-p2011
Diagnostic kit for malignant melanoma2011
Diagnostic agent for malignant melanoma2010